Income statement
USD
Annual
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31K | -28K | -37K | -26K | -29K |
| EBITDA | -31K | -28K | -37K | -26K | -29K |
| Net Income | -31K | -28K | -37K | -26K | -29K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$7.51
+0.00% today
1Y Change
+1.35%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 254 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
World Financial Holding Group (WFHG) is a Healthcare stock with a market cap of $470.00M and listed on OTC. The stock last traded around $7.51 and up 1.3% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -25.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -25.0%, free cash flow 0.0% with operating margin 0.0% and ROIC 0.0%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines WFHG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
WFHG
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
WFHG Max Drawdown
-92.93%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for WFHG and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$29.0K
-11.2% YoY
Free Cash Flow
-$26.1K
+3.7% YoY
Revenue Growth
+0.0%
EPS Growth
-25.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -31K | -28K | -37K | -26K | -29K |
| EBITDA | -31K | -28K | -37K | -26K | -29K |
| Net Income | -31K | -28K | -37K | -26K | -29K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Cash & Equivalents | 292 | 5K | 2K | 687 | 6K |
| Total Assets | 292 | 5K | 2K | 687 | 6K |
| Total Liabilities | 133K | 109K | 75K | 48K | 151K |
| Shareholder Equity | -132K | -104K | -73K | -47K | -146K |
| Total Debt | 98K | 78K | 44K | 15K | 120K |
| Net Debt | 98K | 73K | 42K | 14K | 115K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
26K
+3.7% YoY
Capital Expenditures
0
-100.0% YoY
Free Cash Flow
26K
+3.7% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.0%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.